4928 — Noevir Holdings Co Balance Sheet
0.000.00%
- ¥156bn
- ¥130bn
- ¥65bn
- 88
- 47
- 68
- 81
Annual balance sheet for Noevir Holdings Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 31,101 | 29,747 | 28,883 | 29,223 | 26,930 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,123 | 12,354 | 13,546 | 10,783 | 12,103 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 51,128 | 50,569 | 51,175 | 50,148 | 48,884 |
| Net Property, Plant And Equipment | 22,041 | 20,692 | 20,193 | 19,907 | 21,397 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 80,448 | 76,781 | 77,246 | 76,471 | 76,492 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,639 | 9,653 | 10,506 | 9,323 | 9,847 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 28,521 | 24,725 | 24,456 | 22,993 | 22,724 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 51,927 | 52,056 | 52,790 | 53,478 | 53,768 |
| Total Liabilities & Shareholders' Equity | 80,448 | 76,781 | 77,246 | 76,471 | 76,492 |
| Total Common Shares Outstanding |